Biotwin
BioTwin builds human virtual twin technology from LC-MS metabolomics of dried blood spot samples, integrating wearables and longitudinal data into personalized Bio-Signatures. It serves UAE clinicians with a Cancer Screening CDSS (regulatory-approved) and global consumers via the TwinMe wellness subscription brand.
- Company typePrivate
- Founded2021
- HeadquartersQuebec, Canada
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What Biotwin does
BioTwin builds human virtual twin technology that converts biological signals, lifestyle context, and longitudinal change into personalized Bio-Signatures for preventive health and clinical decision support. The core technology analyzes 30,000+ biomarker-derived metabolic signals per dried blood spot (DBS) sample using high-resolution LC-MS metabolomics in BioTwin's own laboratory, combined with wearable data (Garmin, Apple, Oura), health history, and longitudinal tracking. Outputs are produced through machine learning classifiers (LASSO, Elastic Net, SVM linear, PLS-DA, OPLS-DA, XGBoost) and a personal-baseline comparison methodology rather than population averages, with batch-aware (GroupKFold) validation to avoid optimistic performance estimates.
The company operates a dual-brand model. The regulated BioTwin clinical pathway delivers a Cancer Screening Clinical Decision Support System (CDSS) for breast and colorectal cancer, currently available only through participating physicians in authorized UAE clinical settings under Department of Health Abu Dhabi approval; Health Canada and FDA reviews are pending. The non-medical TwinMe consumer brand (sold via twinme.ai) is the primary commercial surface today, offering four prepaid subscription programs (Elite Health Optimization, Weight Management, Healthspan/Longevity, Apex Sport Performance) with a $595 entry kit offer. Revenue mechanics combine one-time DBS kit sales, prepaid subscriptions (monthly/quarterly/annual), and enterprise clinical/provider access through the BioTwin Portal.
BioTwin is structured as BioTwin Holding International (Quebec parent) owning BioTwin Canada Inc. and BioTwin Limited (UAE), with BioTwin USA planned. The company has raised approximately C$6.1M in disclosed funding across 2021 (C$2.5M) and 2022 (C$3.6M) from Investissement Québec, the Government of Canada (via CED), and NRC IRAP, with later non-dilutive support from MBRIF and Mubadala. It holds 3 patents (plus a PCT pending) and has produced 1 peer-reviewed publication and 3 preprints covering biometrics identification (94.1% user-level accuracy, n=1,257), breast cancer detection (AUC 0.928–0.949, n=2,734), ME/CFS fatigue convergence (n=1,784), and wearable inter-device agreement. Clinical and research partnerships include Abu Dhabi Biobank (flagship), Cleveland Clinic Abu Dhabi, Al Jalila Hospital, Harvard Medical School, Université Laval, Concordia University, and Institut de Cardiologie de Québec, alongside technology ecosystem partners Microsoft for Startups, Google for Startups Accelerator Canada, NVIDIA Inception, AWS, and IBM.
Biotwin firmographics
Firmographics- Name
- Biotwin
- Legal name
- BioTwin Holding International
- Website
- https://biotwin.ai
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BioTwin builds human virtual twin technology from LC-MS metabolomics of dried blood spot samples, integrating wearables and longitudinal data into personalized Bio-Signatures. It serves UAE clinicians with a Cancer Screening CDSS (regulatory-approved) and global consumers via the TwinMe wellness subscription brand.
- Ownership category
- akta.pro rank
Biotwin industry classification
Industry- Product category
- Digital Health / Preventive Health Technology
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Biomarker Discovery & Validation (omics, assay feasibility, clinical validation) (HLAAAMAA)
- akta.pro secondary industries
- Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Translational & Pharmacodynamic Biomarkers (MOA, target engagement, PD/PK-linked markers) (HLAAAMAD), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL), Translational Medicine & Biomarkers (HLAIALAF)
Keywords
Where Biotwin is headquartered
LocationHeadquarters
- HQ city
- Quebec
- HQ country
- Canada
- HQ region
- North America
Offices2 records
Markets served
Biotwin business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales, Others
Revenue model
- Biological Kit Sales (One-time Purchase): BioTwin Offer at $595 unlocks two 50% off biological kits for the purchaser or loved ones ($595 in gift value). This appears to be a one-time purchase model for the sample collection kit with associated analysis.
- Subscription Plans (Prepaid): Prepaid subscription plans available (monthly, quarterly, annual) for ongoing TwinMe wellness programs including Elite Health Optimization, Weight Management, Healthspan/Longevity, and Apex Sport Performance. Users can cancel plans at end of current period with unused services refundable pro-rata on annual plans.
- Clinical Cancer Screening Decision Assistance (UAE): BioTwin's cancer screening decision-assistance pathway available through participating physicians in authorized UAE clinical settings for breast and colorectal cancer screening. This represents the regulated clinical revenue stream, pending regulatory approval in Canada and U.S.
- Provider and Research Programs: BioTwin provides portal, dashboards, reports, and features intended for healthcare providers, clinics, wellness professionals, employers, and partner organizations through BioTwin Portal programs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | BioTwin Offer - $595 for entry |
| Subscription | Monthly | Elite Health Optimization Program |
| Subscription | Monthly | Weight Management Program |
| Subscription | Monthly | Healthspan / Longevity Program |
| Subscription | Monthly | Apex Sport Performance Program |
| Subscription | Annual | Prepaid Subscription Plans |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels7 records
Biotwin product offering
Product offeringCore offering
BioTwin builds human virtual twin technology that transforms biological signals, lifestyle context, and longitudinal change over time into personalized Bio-Signatures. The platform analyzes 30,000+ biomarker-derived metabolic signals per dried blood spot sample via high-resolution LC-MS metabolomics, integrates wearable device data, lifestyle inputs, and health history, and delivers the offering through two tiers: a regulated clinical Cancer Screening Decision Support System available to physicians in UAE and the TwinMe consumer wellness brand with subscription programs.
Product overview
BioTwin offers a two-tier product architecture: BioTwin (clinical/regulated) and TwinMe (non-medical wellness). The BioTwin platform consists of four technology layers: home sample collection kit, analytical chemistry (LC-MS metabolomics), advanced AI analytics, and virtual twin technology. The clinical offering includes the Cancer Screening CDSS (available in authorized UAE settings for breast and colorectal cancer screening) with a roadmap expanding to cardiology and neurology. The consumer-facing TwinMe brand offers four distinct wellness programs (Elite Health Optimization, Weight Management, Healthspan/Longevity, and Apex Sport Performance) built on the same virtual twin technology but positioned as non-medical wellness experiences. The platform integrates wearable data from Garmin, Apple, and Oura devices, processes 30,000+ biomarker-derived metabolic signals per biological sample, and supports longitudinal health monitoring across oncology, cardiology, and neurology clinical areas.
Differentiator
Problem solved
Functional benefit
Brands
- TwinMe: Non-medical wellness brand owned by BioTwin Holding and licensed to BioTwin operating entities. Provides wellness experiences powered by BioTwin's virtual twin technology, including programs for Elite Health Optimization, Weight Management, Healthspan/Longevity, and Apex Sport Performance.
Products and services
- BioTwin Virtual Human Twin Technology Core platform that transforms biological signals, lifestyle context, and longitudinal change into personalized Bio-Signatures and a virtual twin model of human health for use across both regulated clinical and consumer wellness applications.
- TwinMe Wellness Brand
Quantifiable outcome
- 94.1% user-level accuracy in individual identification across 1,257 participants, 18,288 samples, and 134 analytical batches
- +3 more outcomes
Companies that use Biotwin
Customer profileNamed customers8 records
Segments6 records
Ideal customer profiles4 records
Biotwin technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability7 records
Feature7 records
Biotwin partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered flagship and core.
- Abu Dhabi BiobankflagshipStrategic partnership to expand AI-powered Virtual Human Twin technology in the UAE, supporting early disease detection, prevention, and precision healthcare. The agreement combines BioTwin's AI platform with Abu Dhabi Biobank's biological, genomic, and clinical data, with the first phase focusing on multi-cancer screening. Announced at BIO International Convention 2026 in San Diego.
- Cleveland Clinic Abu DhabicoreClinical partnership to pilot virtual human twin technology in breast cancer screening as part of the Oncology Institute at Cleveland Clinic Abu Dhabi. Includes co-authorship on breast cancer detection preprint (Anctil et al., 2026) with Dr. Stephen Grobmyer from Cleveland Clinic Abu Dhabi.
- Harvard Medical SchoolcoreMedical school partner for validation and research collaboration in Boston, USA. Listed on BioTwin's trusted partners validation page.
- Concordia UniversitycoreUniversity partner in Montreal for research collaboration. Listed as healthcare and research partner.
- Université LavalcoreUniversity partner in Quebec for research collaboration. Co-author on breast cancer detection preprint (Caroline Rhéaume) and listed as trusted research partner.
- Institut de Cardiologie de QuébeccoreCardiology institute partner in Quebec for cardiovascular research collaboration. Listed as healthcare and research partner on validation page.
- Al Jalila HospitalcoreSpecialty hospital partner in Dubai, UAE for clinical validation and implementation of virtual twin technology. Listed as healthcare partner on validation page.
- Department of Health, Abu DhabicoreHealth regulator partner in Abu Dhabi for regulatory oversight, clinical approval, and strategic health initiatives. Listed on validation page and involved in active clinical trial approval.
- Microsoft for StartupscoreTechnology partner providing cloud and Azure credits program for startups. Part of Microsoft ecosystem support for BioTwin's AI and cloud infrastructure.
- Google for Startups CanadacoreTechnology accelerator partner for startup ecosystem support. BioTwin was part of the 2024 Google for Startups Accelerator Canada cohort.
- NVIDIA InceptioncoreNVIDIA AI startup program providing technology support, GPU resources, and ecosystem access for AI/ML development.
- AWScoreAmazon Web Services cloud infrastructure partner for computing, storage, and cloud services.
- IBMcoreEnterprise cloud and HPC (High Performance Computing) partner for advanced computing infrastructure. Listed alongside AWS on validation page.
- Hub71coreAbu Dhabi tech ecosystem partner welcoming BioTwin as part of their 14th cohort for startup support and regional market access.
- Microsoft Entrepreneurship for Positive ImpactcoreMicrosoft impact-startup program providing support and resources for startups focused on positive social impact.
Scale indicators10 records
Recent moves6 records
Expansion highlights6 records
Biotwin competitors and assessment
Company assessmentDirect peers
- Function Health: Function Health is a direct-to-consumer preventative health platform offering comprehensive blood biomarker testing and longitudinal health insights, comparable to BioTwin's TwinMe wellness offering. Both target health-conscious consumers seeking multi-marker biological profiling and use subscription models with follow-up testing over time.
- InsideTracker: InsideTracker combines blood biomarker analysis with wearable data and lifestyle inputs to deliver personalized health and longevity recommendations. It is one of the closest direct competitors to TwinMe's personalized wellness programs, sharing the same longitudinal biological monitoring value proposition.
- Viome Life Sciences: Viome analyzes microbiome and blood transcriptomic/metabolomic signals to generate personalized health and nutrition recommendations via subscription. Comparable to BioTwin in applying high-dimensional omics and AI to consumer-facing preventative health insights.
- Elysium Index: Elysium's Index offering uses a multi-omic blood test to assess biological age and healthspan-relevant biomarkers, serving consumers interested in longevity. Directly comparable to BioTwin's Healthspan/Longevity program in concept, modality (blood-based omics), and target buyer.
- Fountain Life: Fountain Life operates preventative health and longevity centers using advanced diagnostics (imaging, blood biomarkers, AI) to detect disease early. Comparable to BioTwin in combining multi-omic biomarkers with longitudinal health tracking and a premium preventative positioning.
Broad incumbents
- Thorne HealthTech: Thorne is an established supplements and health testing company with direct-to-consumer biomarker panels and personalized wellness programs. Comparable to BioTwin's consumer offering but with a broader supplements portfolio and more mature D2C infrastructure.
- Cleveland HeartLab (Quest Diagnostics): Cleveland HeartLab, now part of Quest Diagnostics, offers advanced cardiovascular biomarker testing through a clinical lab network. Relevant as an incumbent clinical biomarker lab with established CLIA infrastructure, comparable to BioTwin's specialty biomarker services path.
- Human Longevity Inc. HLI combines whole-genome sequencing, advanced imaging, and metabolomics in a comprehensive executive health platform. Comparable to BioTwin in scope of biological measurement and longitudinal health model ambition, though at a more mature and capital-intensive scale.
Emerging players
- Tally Health: Tally Health offers a biological age test and longevity-focused supplement program targeting health-conscious consumers. Comparable to BioTwin's Healthspan/Longevity program in consumer value proposition but narrower in analytical breadth.
Others
- Metabolon: Metabolon is a metabolomics services and biomarker discovery company providing untargeted metabolomics for research and clinical applications. Comparable as a metabolomics infrastructure peer, though positioned as a B2B services platform rather than a direct-to-consumer virtual twin.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Biotwin social profiles
Digital presenceBiotwin financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biotwin leadership team
Management profileNumber of profiles
Profiles1 record
Biotwin funding detail
Funding detailFunding overview
Funding rounds3 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biotwin M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biotwin
What does Biotwin do?
BioTwin builds human virtual twin technology that transforms biological signals, lifestyle context, and longitudinal change over time into personalized Bio-Signatures. The platform analyzes 30,000+ biomarker-derived metabolic signals per dried blood spot sample via high-resolution LC-MS metabolomics, integrates wearable device data, lifestyle inputs, and health history, and delivers the offering through two tiers: a regulated clinical Cancer Screening Decision Support System available to physicians in UAE and the TwinMe consumer wellness brand with subscription programs.
Is Biotwin a public or private company?
Biotwin is a private company. It is classified as venture growth investor backed and is currently operating.
When was Biotwin founded?
Biotwin was founded in 2021. It employs 11 to 50 people.
Where is Biotwin based?
Biotwin is headquartered in Quebec, Canada, in the North America region.
How does Biotwin make money?
Four revenue lines are on record. Biological Kit Sales (One-time Purchase) is the primary driver. The others are subscription Plans (Prepaid), clinical Cancer Screening Decision Assistance (UAE) and provider and Research Programs.
Who are Biotwin's main competitors?
Direct peers on record are Function Health, InsideTracker, Viome Life Sciences, Elysium Index and Fountain Life. Broad incumbents are Thorne HealthTech, Cleveland HeartLab (Quest Diagnostics) and Human Longevity Inc.. Tally Health is listed as an emerging player. Metabolon is listed as an others.
Does Biotwin have an API?
No public API is recorded for Biotwin.
What industry is Biotwin in?
Biotwin's product category is Digital Health / Preventive Health Technology. Its primary akta.pro industry code is HLAAAMAA, Biomarker Discovery & Validation (omics, assay feasibility, clinical validation), with a secondary code of HLAAAMAC, Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays). Its NAICS code is 541714 and its SIC code is 2835.